Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study
DeNucci et al., Pulmonary Pharmacology & Therapeutics, doi:10.1016/j.pupt.2023.102212
https://c19early.org/denucci.html